REGULUS THERAPEUTICS INC - COM NEW (RGLS)

CUSIP: 75915K200

Q4 2018 13F Holders as of 31 Dec 2018

Type / Class
Equity / COM NEW
Total 13F shares
2,624,560
Share change
+2,497,475
Total reported value
$2,439,420
Price per share
$0.92
Number of holders
21
Value change
+$2,322,910
Number of buys
20
Number of sells
1

Quarterly Holders Quick Answers

What is CUSIP 75915K200?
CUSIP 75915K200 identifies RGLS - REGULUS THERAPEUTICS INC - COM NEW in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of REGULUS THERAPEUTICS INC - COM NEW (RGLS) as of Q4 2018

As of 31 Dec 2018, REGULUS THERAPEUTICS INC - COM NEW (RGLS) was held by 21 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 2,624,560 shares. The largest 10 holders included BVF INC/IL, NEA Management Company, LLC, Vanguard Group Inc, RENAISSANCE TECHNOLOGIES LLC, BlackRock Inc., GEODE CAPITAL MANAGEMENT, LLC, WEDBUSH SECURITIES INC, Bank of New York Mellon Corp, PANAGORA ASSET MANAGEMENT INC, and TWO SIGMA INVESTMENTS, LP. This page lists 21 institutional shareholders reporting positions in this security for the Q4 2018 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.